Literature DB >> 2792185

Interleukin 5 regulation of peritoneal Ly-1 B lymphocyte proliferation, differentiation and autoantibody secretion.

G D Wetzel1.   

Abstract

The in vitro effects of recombinant interleukin (IL) 5 on proliferation and maturation of mouse Ly-1 B cells were studied. Most freshly isolated peritoneal Ly-1 B cells expressed high levels of IL5 receptor (R). Limiting dilution analyses showed that mitogens could reveal IL5 responsiveness in more than half of low density peritoneal Ly-1 B cells. IL 5 was able not only to increase the proportion of these Ly-1 B cells induced to proliferate, but it also shifted the clone size distribution of proliferating cells towards larger clone sizes. Splenic Ly-1 B cells also proliferated in response to mitogens plus IL5. Spontaneous and polyclonal activator-induced plaque-forming cell responses of Ly-1 B cells were increased by IL5. Furthermore, IL5 increased the frequency of peritoneal Ly-1 B cells induced to secrete certain autoantibodies. IL5 was certainly the agent responsible since its effects on both proliferation and differentiation were inhibited by either anti-IL5R monoclonal antibodies or by anti-IL5 monoclonal antibodies. Hence, Ly-1 B cells, IL5 and the IL5R appear to constitute a system of cellular proliferation, differentiation and some autoantibody production. Strategies specifically targeting the interleukin and receptor elements of this system might afford external control of these cellular responses.

Entities:  

Mesh:

Substances:

Year:  1989        PMID: 2792185     DOI: 10.1002/eji.1830190926

Source DB:  PubMed          Journal:  Eur J Immunol        ISSN: 0014-2980            Impact factor:   5.532


  12 in total

1.  T cell control of the gut IgA response against commensal bacteria.

Authors:  N A Bos; H Q Jiang; J J Cebra
Journal:  Gut       Date:  2001-06       Impact factor: 23.059

2.  IL-5 links adaptive and natural immunity specific for epitopes of oxidized LDL and protects from atherosclerosis.

Authors:  Christoph J Binder; Karsten Hartvigsen; Mi-Kyung Chang; Marina Miller; David Broide; Wulf Palinski; Linda K Curtiss; Maripat Corr; Joseph L Witztum
Journal:  J Clin Invest       Date:  2004-08       Impact factor: 14.808

Review 3.  Transgenic mice in the study of cytokine function.

Authors:  J Taverne
Journal:  Int J Exp Pathol       Date:  1993-12       Impact factor: 1.925

4.  Integrated Cellular and Plasma Proteomics of Contrasting B-cell Cancers Reveals Common, Unique and Systemic Signatures.

Authors:  Harvey E Johnston; Matthew J Carter; Kerry L Cox; Melanie Dunscombe; Antigoni Manousopoulou; Paul A Townsend; Spiros D Garbis; Mark S Cragg
Journal:  Mol Cell Proteomics       Date:  2017-01-04       Impact factor: 5.911

5.  Murine B1 B cells require IL-5 for optimal T cell-dependent activation.

Authors:  L D Erickson; T M Foy; T J Waldschmidt
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

6.  IL-4 down-regulates the surface expression of CD5 on B cells and inhibits spontaneous immunoglobulin and IgM-rheumatoid factor production in patients with rheumatoid arthritis.

Authors:  T Hidaka; A Kitani; M Hara; M Harigai; K Suzuki; Y Kawaguchi; T Ishizuka; M Kawagoe; H Nakamura
Journal:  Clin Exp Immunol       Date:  1992-08       Impact factor: 4.330

7.  Molecular basis of a high affinity murine interleukin-5 receptor.

Authors:  R Devos; G Plaetinck; J Van der Heyden; S Cornelis; J Vandekerckhove; W Fiers; J Tavernier
Journal:  EMBO J       Date:  1991-08       Impact factor: 11.598

8.  Ancient T-independence of mucosal IgX/A: gut microbiota unaffected by larval thymectomy in Xenopus laevis.

Authors:  S Mashoof; A Goodroe; C C Du; J O Eubanks; N Jacobs; J M Steiner; I Tizard; J S Suchodolski; M F Criscitiello
Journal:  Mucosal Immunol       Date:  2012-08-29       Impact factor: 7.313

9.  B-1a, B-1b and B-2 B cells display unique VHDJH repertoires formed at different stages of ontogeny and under different selection pressures.

Authors:  U C Tornberg; D Holmberg
Journal:  EMBO J       Date:  1995-04-18       Impact factor: 11.598

10.  Molecular cloning and expression of the human interleukin 5 receptor.

Authors:  Y Murata; S Takaki; M Migita; Y Kikuchi; A Tominaga; K Takatsu
Journal:  J Exp Med       Date:  1992-02-01       Impact factor: 14.307

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.